Krystal Biotech, Inc. (KRYS) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-03
(Q2 2026)
— full calendar
Earnings Reports
-
Crystal Biotech (KRYS) Q1 2026: Ex-US Revenue Jumps 39% as Global Launch Diversifies Growth
May 04, 2026
-
Crystal Biotech (KRYS) Q4 2025: Ex-US Launches Drive 18% Revenue Growth as Global Expansion Accelerates
February 23, 2026
-
Krystal Biotech (KRYS) Q3 2025: Gross Margin Jumps to 96% as Global Launches Expand
November 03, 2025
-
Crystal Biotech (KRYS) Q2 2025: Vizuvac Revenue Climbs 9% as Global Launches Anchor Multi-Year Growth
August 04, 2025
-
Crystal Biotech (KRYS) Q1 2025: 95% Revenue Growth Anchors Global Vizuvac Expansion
July 07, 2025